Expert Q&A: OneLab—Pathology Meets Virtual Reality
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.
An overview of what will happen to the COVID-19 tests issued via EUA once the public health emergency ends on May 11.
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Experts share new strategies for dealing with hemolysis, icterus, and lipemia interference.
In a new practice guideline, the group also “strongly recommends” that NIPS be offered to patients to screen for fetal SCA.
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
The test manufacturer is the first to gain IVDR certification for a companion diagnostic under the new regulation.
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.